Automated Biopsy System Featured at NCBC

March 6, 2008 - Featured at NCBC 2008, the Cassi II Rotational Core Biopsy System by Sanarus Medical is reportedly the first large core biopsy device that is fully automated, self contained, hand-held and disposable.

The Visica Treatment System uses cryoablation as a minimally invasive means to surround and destroy a fibroadenoma in a lethal ball of ice. Throughout the procedure, ultrasound visualization provides, added safety and confirmation that the iceball has fully engulfed the fibroadenoma, said the company. This procedure can be performed in an office in about 30 minutes, using local anesthesia. This "in- office cryoablation technology" destroys fibroadenomas as an alternative to surgical excision, said Sanarus.

For more information: www.sanarus.com

Related Content

Serena Bright sets new standards for breast cancer detection and biopsy technology

News | Breast Biopsy Systems

GE Healthcare’s Industry-First Contrast-Guided Biopsy Solution, Serena Bright, Installed in Five Major Hospitals in the United States

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

July 07, 2021

Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care

News | Breast Imaging

Hologic to Acquire SOMATEX, Leader in Biopsy Site Markers and Localization Technologies

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...

January 04, 2021

News | Prostate Cancer

Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.

August 20, 2019

News | Biopsy Systems

Dune Medical Launches First-in-Man Trial for Smart Biopsy Device

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.

March 29, 2019

Technology | Interventional Radiology

FDA Clears Ion Endoluminal Lung Biopsy System

The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

February 20, 2019

News | Prostate Cancer

Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer

Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.

February 12, 2019

News | Breast Biopsy Systems

Novel Technique May Significantly Reduce Breast Biopsies

A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology

January 17, 2019